Generating Developable 3D Molecules via Pocket-Conditioned Diffusion and Property-Aware Optimization

• URL: http://arxiv.org/abs/2607.12349v1
• Date: Tue, 14 Jul 2026 04:52:25 GMT
• Title: Generating Developable 3D Molecules via Pocket-Conditioned Diffusion and Property-Aware Optimization
• Abstract summary: conDitar-dev is a conditional diffusion-based structure-based drug design framework.<n>It generates molecules with strong binding affinities and favorable ADMET properties.<n>It outperforms state-of-the-art SBDD baselines, achieving an average binding score of -8.85 kcal/mol.<n>Across five ADMET properties, conDitar-dev improves performance by up to 73% over conDitar.
• Score: 13.733965040667792
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Drug discovery and development is time-consuming and resource-intensive, motivating computational approaches such as diffusion models for de novo drug design. Many such models follow the structure-based drug design (SBDD) paradigm, generating molecules to fit a target binding pocket. However, existing diffusion-based SBDD methods typically couple pocket and ligand representation learning, model interactions only at the atom level, and prioritize binding affinity over other developability properties. Here, we introduce conDitar-dev, a conditional diffusion-based SBDD framework for generating ligands with strong binding affinities and favorable ADMET properties. It consists of three modules: msPRL, a pretrained multi-scale pocket representation learning module; conDitar, a pocket-conditioned diffusion model guided by msPRL representations; and paOPT, a generation-time method for optimizing ligand developability. On a newly curated benchmark of human disease targets, conDitar outperforms state-of-the-art SBDD baselines, achieving an average binding score of -8.85 kcal/mol. Across five ADMET properties, conDitar-dev improves performance by up to 73% over conDitar. To further validate the abilities of conDitar-dev to generate developable molecules, we have applied it to two validated druggable targets: programmed death-ligand 1 (PD-L1) and colony-stimulating factor 1 receptor (CSF1R) proteins. Top-ranked generatively designed molecules and their analogs have been experimentally synthesized and biologically tested. Two molecules generated directly by conDitar-dev for PD-L1 exhibited SPR-derived $K_D$ values of 3.49 and 3.75 $μ$M, respectively. Hit expansion based on conDitar-dev-designed molecules identified selective CSF1R inhibitors with IC$_{50}$ values as low as 200 nM, while also uncovering opportunities for drug repositioning.

Related papers

• Fine-tuning Pocket-Aware Diffusion Models via Denoising Policy Optimization [6.296632663190645]
  We present DEPPA, a novel structure-based molecule optimization (SBMO) approach for fine-tuning a pre-trained pocket-aware diffusion model.<n> DEPPA enables optimization over multiple properties, including binding affinity, drug-likeness, synthesizability and diversity.
  arXiv  Detail & Related papers  (2026-05-17T23:21:24Z)
• Zatom-1: A Multimodal Flow Foundation Model for 3D Molecules and Materials [51.342983349686556]
  General-purpose 3D chemical modeling encompasses molecules and materials, requiring both generative and predictive capabilities.<n>We introduce Zatom-1, the first end-to-end, fully open-source foundation model that unifies generative and predictive learning of 3D molecules and materials.
  arXiv  Detail & Related papers  (2026-02-24T20:52:39Z)
• Generative molecule evolution using 3D pharmacophore for efficient Structure-Based Drug Design [8.652951659846838]
  We propose an evolutionary framework named MEVO, which bridges the gap between billion-scale small molecule dataset and the scarce protein-ligand complex dataset.<n>MEVO is composed of three key components: a high-fidelity VQ-VAE for molecule representation in latent space, a diffusion model for pharmacophore-guided molecule generation, and a pocket-aware evolutionary strategy for molecule optimization.
  arXiv  Detail & Related papers  (2025-07-27T04:58:11Z)
• BAPULM: Binding Affinity Prediction using Language Models [7.136205674624813]
  We introduce BAPULM, an innovative sequence-based framework that leverages the chemical latent representations of proteins via ProtT5-XL-U50 and through MolFormer. Our approach was validated extensively on benchmark datasets, achieving sequential scoring power (R) values of 0.925 $pm$ 0.043, 0.914 $pm$ 0.004, and 0.8132 $pm$ 0.001 on benchmark1k2101, Test2016_290, and CSAR-HiQ_36, respectively.
  arXiv  Detail & Related papers  (2024-11-06T04:35:30Z)
• Conditional Synthesis of 3D Molecules with Time Correction Sampler [58.0834973489875]
  Time-Aware Conditional Synthesis (TACS) is a novel approach to conditional generation on diffusion models. It integrates adaptively controlled plug-and-play "online" guidance into a diffusion model, driving samples toward the desired properties.
  arXiv  Detail & Related papers  (2024-11-01T12:59:25Z)
• Decomposed Direct Preference Optimization for Structure-Based Drug Design [47.561983733291804]
  We propose DecompDPO, a structure-based optimization method to align diffusion models with pharmaceutical needs. DecompDPO can be effectively used for two main purposes: fine-tuning pretrained diffusion models for molecule generation across various protein families, and molecular optimization given a specific protein subpocket after generation.
  arXiv  Detail & Related papers  (2024-07-19T02:12:25Z)
• Aligning Target-Aware Molecule Diffusion Models with Exact Energy Optimization [147.7899503829411]
  AliDiff is a novel framework to align pretrained target diffusion models with preferred functional properties. It can generate molecules with state-of-the-art binding energies with up to -7.07 Avg. Vina Score.
  arXiv  Detail & Related papers  (2024-07-01T06:10:29Z)
• DecompDiff: Diffusion Models with Decomposed Priors for Structure-Based Drug Design [62.68420322996345]
  Existing structured-based drug design methods treat all ligand atoms equally. We propose a new diffusion model, DecompDiff, with decomposed priors over arms and scaffold. Our approach achieves state-of-the-art performance in generating high-affinity molecules.
  arXiv  Detail & Related papers  (2024-02-26T05:21:21Z)
• Functional-Group-Based Diffusion for Pocket-Specific Molecule Generation and Elaboration [63.23362798102195]
  We propose D3FG, a functional-group-based diffusion model for pocket-specific molecule generation and elaboration. D3FG decomposes molecules into two categories of components: functional groups defined as rigid bodies and linkers as mass points. In the experiments, our method can generate molecules with more realistic 3D structures, competitive affinities toward the protein targets, and better drug properties.
  arXiv  Detail & Related papers  (2023-05-30T06:41:20Z)
• Structure-based Drug Design with Equivariant Diffusion Models [40.73626627266543]
  We present DiffSBDD, an SE(3)-equivariant diffusion model that generates novel conditioned on protein pockets. Our in silico experiments demonstrate that DiffSBDD captures the statistics of the ground truth data effectively. These results support the assumption that diffusion models represent the complex distribution of structural data more accurately than previous methods.
  arXiv  Detail & Related papers  (2022-10-24T15:51:21Z)
• MIMOSA: Multi-constraint Molecule Sampling for Molecule Optimization [51.00815310242277]
  generative models and reinforcement learning approaches made initial success, but still face difficulties in simultaneously optimizing multiple drug properties. We propose the MultI-constraint MOlecule SAmpling (MIMOSA) approach, a sampling framework to use input molecule as an initial guess and sample molecules from the target distribution.
  arXiv  Detail & Related papers  (2020-10-05T20:18:42Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.